PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway
PRDX1 knockdown facilitates erastin-induced ferroptosis and obstacles DLBCL progression by inhibiting the MAPK/ERK pathway, offering a potential treatment strategy for DLBCL treatment.
Authors
- M. Wang (ORCID: https://orcid.org/0009-0000-9433-392X)
- Shuiling Xie (ORCID: https://orcid.org/0009-0002-3575-1157)
- Jianzhen Shen (ORCID: https://orcid.org/0009-0003-8586-267X)
- Chuanming Lin
Institutions
- Fujian Medical University (CN)
- Gannan Medical University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1186/s12885-025-14173-1
- Citations
- 6
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 9.11